tiprankstipranks
Trending News
More News >

NeuroScientific Biopharmaceuticals Completes Acquisition of StemSmart Technology

Story Highlights
  • NeuroScientific Biopharmaceuticals acquires Isopogen WA, securing StemSmart™ technology.
  • Focus shifts to Crohn’s disease treatment program, with new leadership appointments.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
NeuroScientific Biopharmaceuticals Completes Acquisition of StemSmart Technology

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ).

NeuroScientific Biopharmaceuticals Ltd has completed the acquisition of Isopogen WA, gaining full rights to the StemSmart™ patented stem cell technology. This strategic move positions the company to focus on a Special Access Program for treating fistulising Crohn’s disease, a condition with limited treatment options. The company has also announced new board appointments, with Robert McKenzie as the Non-Executive Chairman, signaling a strategic shift towards advancing clinical programs and seeking regulatory approval for their innovative treatments. The acquisition and new leadership are expected to strengthen the company’s market position and provide alternative treatment options for patients.

More about Neuroscientific Biopharmaceuticals Ltd.

NeuroScientific Biopharmaceuticals Ltd is a company operating in the biopharmaceutical industry, focusing on developing innovative treatments using stem cell technology. Their primary product involves the patented StemSmart™ technology, which enhances the clinical efficacy of mesenchymal stem cells derived from adult human donor bone marrow. The company targets significant markets, including Crohn’s disease, kidney transplants, lung disorders, and graft-versus-host disease.

Average Trading Volume: 428,090

Technical Sentiment Signal: Buy

Current Market Cap: A$13.01M

See more insights into NSB stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1